Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Publication Date: April 25, 2021
Key Points
Key Points
- The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
- The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
- In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.
Treatment
...eatment
...ght-based dosing of cytotoxic chemotherapy...
...l recommends limiting fixed dosing of chemother...
...A-approved prescribing information...
...rescribing information for targeted thera...
...obese patient experiences high-grade toxicity fr...
...Panel recommends that BSA be calculated using a...